Security key
36151G600
- Security type / class
- Equity / COM
- Total 13F shares
- 315,542
- Total 13F value
- $605,841
- Share change
- -281,999
- SEC-reported price per share
- $1.92
- Number of holders
- 8
- Value change
- -$1,340,174
- Number of buys
- 4
- Number of sells
- 10
Report period
Q2 2024
Institutions
8
Top holders
8
INBS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
INTELLIGENT BIO SOLUTIONS INC. SEC filings
INTELLIGENT BIO SOLUTIONS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36151G600
Recent filing periods:
Ownership snapshot
Top reported holders of INBS - INTELLIGENT BIO SOLUTIONS INC. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Life Science Biosensor Di...
Disclosed value leader
Life Science Biosensor Di...
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $2,001,337
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Life Science Biosensor Diagnostics Pty Ltd has the largest disclosed position value at $2M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Life Science Biosensor Diagnostics Pty Ltd's linked filing trail.
Disclosed position value
Top 5
Life Science Biosensor Diagnostic...
$2M
Ma-Ran Foundation
$394.5K
Gary W. Rollins Foundation
$352.4K
Alyeska Investment Group, L.P.
$864.2K
ADAR1 Capital Management, LLC
$456.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Life Science Biosensor Diagnostics Pty Ltd |
3/4/5
Former 10% owner
|
—
denominator unverified
|
$2,001,337
1,081,804 shares
|
— | 17 Feb 2022 |
| Ma-Ran Foundation |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$394,540
213,265 shares
|
— | 12 May 2023 |
| Gary W. Rollins Foundation |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$352,405
190,489 shares
|
— | 12 May 2023 |
| Alyeska Investment Group, L.P. |
13F
Company
|
—
denominator unverified
|
$864,180
206,199 shares
|
— | 31 Mar 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$456,815
108,250 shares
|
— | 31 Mar 2024 |
| CVI Holdings, LLC |
13F
Company
|
—
denominator unverified
|
$456,815
108,250 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
315,542
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q3 2025 Across Filers
Q3 2025 holders
12
Q2 2024 holders
8
Holder diff
-4
| Investor | Q3 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend